{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:39:17Z","timestamp":1790746757850,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PUE 0055"],"award-info":[{"award-number":["PUE 0055"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008392","name":"Fondation Nelia et Amadeo Barletta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional de Promoci\u00f3n de la Investigaci\u00f3n, el Desarrollo Tecnol\u00f3gico y la Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PICT 2021-00449"],"award-info":[{"award-number":["PICT 2021-00449"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27594-6","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:16:02Z","timestamp":1765538162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inflammatory mediators differentially regulate megakaryopoiesis and thrombopoiesis in myelofibrosis and essential thrombocythemia"],"prefix":"10.1038","volume":"15","author":[{"given":"Danila B.","family":"Ya\u00f1uk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela S.","family":"Cellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana F.","family":"Marta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailen D.","family":"Discianni Lupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Glembotsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A. Castro","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Moiraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Sackmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica Cortes","family":"Guerrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula G.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora P.","family":"Goette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Roxana","family":"Lev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"27594_CR1","doi-asserted-by":"publisher","unstructured":"Noh, J. Y. Megakaryopoiesis and Platelet Biology: Roles of transcription factors and emerging clinical implications. Int. J. Mol. Sci. 22, 9615. https:\/\/doi.org\/10.3390\/ijms22179615 (2021).","DOI":"10.3390\/ijms22179615"},{"key":"27594_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-1-61779-307-3_20","volume":"788","author":"M Yu","year":"2012","unstructured":"Yu, M. & Cantor, A. B. Megakaryopoiesis and thrombopoiesis: An update on cytokines and lineage surface markers. Methods Mol. Biol. 788, 291\u2013303. https:\/\/doi.org\/10.1007\/978-1-61779-307-3_20 (2012).","journal-title":"Methods Mol. Biol."},{"key":"27594_CR3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1182\/blood-2015-05-644583","volume":"127","author":"KR Machlus","year":"2016","unstructured":"Machlus, K. R. et al. CCL5 derived from platelets increases megakaryocyte proplatelet formation. Blood 127, 921\u2013926. https:\/\/doi.org\/10.1182\/blood-2015-05-644583 (2016).","journal-title":"Blood"},{"key":"27594_CR4","doi-asserted-by":"crossref","unstructured":"Mascarenhas, J. O., Orazi, A., Bhalla, K. N., Champlin, R. E., Harrison, C. & Hoffman, R. Advances in myelofibrosis: A clinical case approach. Haematologica 98, 1499\u20131509 (2013).","DOI":"10.3324\/haematol.2013.086348"},{"key":"27594_CR5","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1182\/blood-2006-12-064626","volume":"110","author":"SO Ciurea","year":"2007","unstructured":"Ciurea, S. O. et al. Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood 110, 986\u2013993. https:\/\/doi.org\/10.1182\/blood-2006-12-064626 (2007).","journal-title":"Blood"},{"key":"27594_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.hoc.2020.11.004","volume":"35","author":"J Melo-Cardenas","year":"2021","unstructured":"Melo-Cardenas, J., Migliaccio, A. R. & Crispino, J. D. The role of megakaryocytes in myelofibrosis. Hematol. Oncol. Clin. North. Am. 35, 191\u2013203. https:\/\/doi.org\/10.1016\/j.hoc.2020.11.004 (2021).","journal-title":"Hematol. Oncol. Clin. North. Am."},{"key":"27594_CR7","doi-asserted-by":"publisher","first-page":"e21015","DOI":"10.1371\/journal.pone.0021015","volume":"6","author":"A Balduini","year":"2011","unstructured":"Balduini, A. et al. In vitro megakaryocyte differentiation and proplatelet formation in Ph-negative classical myeloproliferative neoplasms: Distinct patterns in the different clinical phenotypes. PLoS One 6, e21015 (2011).","journal-title":"PLoS One"},{"key":"27594_CR8","doi-asserted-by":"publisher","first-page":"1356e1363","DOI":"10.1200\/JCO.2010.32.9490","volume":"29","author":"A Tefferi","year":"2011","unstructured":"Tefferi, A. et al. Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: A comprehensive cytokine profiling study. J. Clin. Oncol. 29, 1356e1363 (2011).","journal-title":"J. Clin. Oncol."},{"key":"27594_CR9","doi-asserted-by":"publisher","first-page":"670580","DOI":"10.1155\/2015\/670580","volume":"2015","author":"J Mondet","year":"2015","unstructured":"Mondet, J., Hussein, K. & Mossuz, P. Circulating cytokine levels as markers of inflammation in Philadelphia negative myeloproliferative neoplasms: Diagnostic and prognostic interest. Mediat. Inflamm. 2015, 670580. https:\/\/doi.org\/10.1155\/2015\/670580 (2015).","journal-title":"Mediat. Inflamm."},{"key":"27594_CR10","doi-asserted-by":"publisher","first-page":"683401","DOI":"10.3389\/fimmu.2021.683401","volume":"12","author":"DAC Fisher","year":"2021","unstructured":"Fisher, D. A. C., Fowles, J. S., Zhou, A. & Oh, S. T. Inflammatory pathophysiology as a contributor to myeloproliferative neoplasms. Front. Immunol. 12, 683401. https:\/\/doi.org\/10.3389\/fimmu.2021.683401 (2021).","journal-title":"Front. Immunol."},{"key":"27594_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0002-9440(10)62056-1","volume":"167","author":"AM Vannucchi","year":"2005","unstructured":"Vannucchi, A. M. et al. Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis. Am. J. Pathol. 167, 849\u2013858. https:\/\/doi.org\/10.1016\/S0002-9440(10)62056-1 (2005).","journal-title":"Am. J. Pathol."},{"key":"27594_CR12","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3324\/haematol.2014.119545","volume":"100","author":"AM Vannucchi","year":"2015","unstructured":"Vannucchi, A. M. et al. A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase 3 trials of ruxolitinib for the treatment of myelofibrosis. Haematologica 100, 1139\u20131145 (2015).","journal-title":"Haematologica"},{"key":"27594_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13045-017-0527-7","volume":"10","author":"S Verstovsek","year":"2017","unstructured":"Verstovsek, S. et al. Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses. J. Hematol. Oncol. 10, 156. https:\/\/doi.org\/10.1186\/s13045-017-0527-7 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"27594_CR14","first-page":"394","volume":"13","author":"RA Mesa","year":"2010","unstructured":"Mesa, R. A. Ruxolitinib a selective JAK1 and JAK2 inhibitor for the treatment of myeloproliferative neoplasms and psoriasis. IDrugs 13, 394\u2013403 (2010).","journal-title":"IDrugs"},{"key":"27594_CR15","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1038\/s41375-019-0379-y","volume":"33","author":"DAC Fisher","year":"2019","unstructured":"Fisher, D. A. C. et al. Cytokine production in myelofibrosis exhibits differential responsiveness to JAKSTAT, MAP Kinase, and NFkappaB signaling. Leukemia 33, 1978\u20131995. https:\/\/doi.org\/10.1038\/s41375-019-0379-y (2019).","journal-title":"Leukemia"},{"key":"27594_CR16","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1038\/leu.2016.377","volume":"31","author":"DAC Fisher","year":"2017","unstructured":"Fisher, D. A. C. et al. Mass cytometry analysis reveals hyperactive NF kappa B signaling in myelofibrosis and secondary acute myeloid leukemia. Leukemia 31, 1962\u20131974. https:\/\/doi.org\/10.1038\/leu.2016.377 (2017).","journal-title":"Leukemia"},{"key":"27594_CR17","first-page":"35","volume":"19","author":"PJ Quesenberry","year":"1991","unstructured":"Quesenberry, P. J. et al. Multifactor stimulation of megakaryocytopoiesis: Effects of Interleukin 6. Exp. Hematol. 19, 35\u201341 (1991). PMID: 1703492.","journal-title":"Exp. Hematol."},{"key":"27594_CR18","doi-asserted-by":"publisher","unstructured":"Beaulieu, L. M. et al. Interleukin 1 receptor 1 and interleukin 1\u03b2 regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. https:\/\/doi.org\/10.1161\/ATVBAHA.113.302700 (2014).","DOI":"10.1161\/ATVBAHA.113.302700"},{"key":"27594_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.thromres.2019.05.008","volume":"179","author":"G Couldwell","year":"2019","unstructured":"Couldwell, G. & Machlus, K. R. Modulation of megakaryopoiesis and platelet production during inflammation. Thromb. Res. 179, 114\u2013120. https:\/\/doi.org\/10.1016\/j.thromres.2019.05.008 (2019).","journal-title":"Thromb. Res."},{"key":"27594_CR20","doi-asserted-by":"publisher","first-page":"1161832","DOI":"10.3389\/fimmu.2023.1161832","volume":"16","author":"G De Luca","year":"2023","unstructured":"De Luca, G. et al. High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis. Front. Immunol. 16, 14:1161832. https:\/\/doi.org\/10.3389\/fimmu.2023.1161832 (2023).","journal-title":"Front. Immunol."},{"key":"27594_CR21","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1038\/sj.onc.1202647","volume":"18","author":"K Balmanno","year":"1999","unstructured":"Balmanno, K. & Cook, S. J. Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 18, 3085\u20133097 (1999).","journal-title":"Oncogene"},{"key":"27594_CR22","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/emboj\/18.5.1367","volume":"8","author":"I Matsumura","year":"1999","unstructured":"Matsumura, I. et al. Transcriptional regulation of the Cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 8, 1367\u20131377 (1999).","journal-title":"EMBO J."},{"key":"27594_CR23","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1128\/MCB.19.4.2690","volume":"19","author":"M Hinz","year":"1999","unstructured":"Hinz, M. et al. NF-kappaB function in growth control: Regulation of Cyclin D1 expression and G0\/G1-to-S-phase transition. Mol. Cell. Biol. 19, 2690\u20132698. https:\/\/doi.org\/10.1128\/MCB.19.4.2690 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"27594_CR24","doi-asserted-by":"publisher","first-page":"e1721","DOI":"10.1038\/cddis.2015.97","volume":"6","author":"MA Debrincat","year":"2015","unstructured":"Debrincat, M. A. et al. BCL-2 is dispensable for thrombopoiesis and platelet survival. Cell. Death Dis. 6, e1721. https:\/\/doi.org\/10.1038\/cddis.2015.97 (2015).","journal-title":"Cell. Death Dis."},{"key":"27594_CR25","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3390\/antiox9111037","volume":"9","author":"A Allegra","year":"2020","unstructured":"Allegra, A. et al. Synergic crosstalk between Inflammation, oxidative Stress, and genomic alterations in BCR-ABL-negative myeloproliferative neoplasm. Antioxidants 9, 1037. https:\/\/doi.org\/10.3390\/antiox9111037 (2020).","journal-title":"Antioxidants"},{"key":"27594_CR26","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1182\/blood-2010-07-293092","volume":"117","author":"ZJ Liu","year":"2011","unstructured":"Liu, Z. J. et al. Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. Blood 117, 4106\u20134117 (2011).","journal-title":"Blood"},{"key":"27594_CR27","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1182\/blood.V99.3.888","volume":"99","author":"G Mattia","year":"2002","unstructured":"Mattia, G. et al. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34\u2009+\u2009cells are correlated with different levels of platelet release. Blood 99, 888\u2013897 (2002).","journal-title":"Blood"},{"key":"27594_CR28","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/art.10870","volume":"48","author":"RM Fleischmann","year":"2003","unstructured":"Fleischmann, R. M. et al. Anakinra, a Recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial. Arthritis Rheum. 48, 927\u2013934. https:\/\/doi.org\/10.1002\/art.10870 (2003).","journal-title":"Arthritis Rheum."},{"key":"27594_CR29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2165\/00003495-200969050-00007","volume":"69","author":"V Oldfield","year":"2009","unstructured":"Oldfield, V., Dhillon, S. & Plosker, G. L. Tocilizumab: A review of its use in the management of rheumatoid arthritis. Drugs 69, 609\u2013632. https:\/\/doi.org\/10.2165\/00003495-200969050-00007 (2009).","journal-title":"Drugs"},{"key":"27594_CR30","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1038\/s41467-022-32927-4","volume":"13","author":"S Rai","year":"2022","unstructured":"Rai, S. et al. Inhibition of interleukin-1\u03b2 reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm. Nat. Commun. 13, 5346. https:\/\/doi.org\/10.1038\/s41467-022-32927-4 (2022).","journal-title":"Nat. Commun."},{"key":"27594_CR31","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1038\/s41467-022-32928-3","volume":"13","author":"MF Rahman","year":"2022","unstructured":"Rahman, M. F. et al. Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm. Nat. Commun. 13, 5347. https:\/\/doi.org\/10.1038\/s41467-022-32928-3 (2022).","journal-title":"Nat. Commun."},{"key":"27594_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1365-2141.2005.05416.x","volume":"129","author":"PS Goerttler","year":"2005","unstructured":"Goerttler, P. S. et al. Gene expression profiling in polycythaemia vera: Overexpression of transcription factor NF-E2. Br. J. Hematol. 129, 138\u2013150 (2005).","journal-title":"Br. J. Hematol."},{"key":"27594_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1182\/blood-2009-11-254664","volume":"116","author":"W Wang","year":"2010","unstructured":"Wang, W., Schwemmers, S., Hexner, E. O. & Pahl, H. L. AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2. Blood 116, 254\u2013266 (2010).","journal-title":"Blood"},{"key":"27594_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.20110540","volume":"209","author":"KB Kaufmann","year":"2012","unstructured":"Kaufmann, K. B. et al. A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2. J. Exp. Med. 209, 35\u201350 (2012).","journal-title":"J. Exp. Med."},{"key":"27594_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5966\/sctm.2012-0046","volume":"2","author":"R Bogeska","year":"2013","unstructured":"Bogeska, R. & Pahl, H. L. Elevated nuclear factor erythroid-2 levels promote epo-independent erythroid maturation and recapitulate the hematopoietic stem cell and common myeloid progenitor expansion observed in polycythemia Vera patients. Stem Cells Transl Med. 2, 112\u2013117 (2013).","journal-title":"Stem Cells Transl Med."},{"key":"27594_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.598182","author":"P Chen","year":"2021","unstructured":"Chen, P. et al. Cytokine consistency between bone marrow and peripheral blood in patients with Philadelphia-Negative myeloproliferative neoplasms. Front. Med. (Lausanne). https:\/\/doi.org\/10.3389\/fmed.2021.598182 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"27594_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1126\/science.aap8861","volume":"360","author":"M Decker","year":"2018","unstructured":"Decker, M., Leslie, J., Liu, Q. & Ding, L. Hepatic thrombopoietin is required for bone marrow hematopoietic stem cell maintenance. Science 360, 106\u2013110 (2018).","journal-title":"Science"},{"key":"27594_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/bjh.13519","volume":"171","author":"C Keohane","year":"2015","unstructured":"Keohane, C. et al. JAK Inhibition induces silencing of T helper cytokine secretion and a profound reduction in T regulatory cells. Br. J. Haematol. 171, 60\u201373. https:\/\/doi.org\/10.1111\/bjh.13519 (2015).","journal-title":"Br. J. Haematol."},{"key":"27594_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03572-3","author":"RK Rampal","year":"2025","unstructured":"Rampal, R. K. et al. Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: A randomized phase 3 trial. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-025-03572-3 (2025).","journal-title":"Nat. Med."},{"key":"27594_CR40","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405 (2016).","journal-title":"Blood"},{"key":"27594_CR41","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1538-7836.2008.03132.x","volume":"6","author":"A Balduini","year":"2008","unstructured":"Balduini, A. et al. Adhesive receptors, extracellularproteins, and myosin-IIa orchestrate proplatelet formation by HumanMK. J. Thromb. Haemost. 6, 1900\u20131907 (2008).","journal-title":"J. Thromb. Haemost"},{"key":"27594_CR42","doi-asserted-by":"publisher","first-page":"1365015","DOI":"10.3389\/fimmu.2024.1365015","volume":"25","author":"G De Luca","year":"2024","unstructured":"De Luca, G. et al. Elevated levels of damage-associated molecular patterns HMGB1 and S100A8\/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis. Front. Immunol. 25, 15:1365015. https:\/\/doi.org\/10.3389\/fimmu.2024.1365015 (2024).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27594-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27594-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27594-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:16:04Z","timestamp":1765538164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27594-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27594"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27594-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43716"}}